Breaking News
19 hours ago
Simantini Singh Deo

FDA cleared 131 drugs in 2025, surpassing the 10-year average and intensifying manufacturing scale-up and CMO capacity demands.
Simantini Singh Deo

Japan's MHLW grants Sanofi dual marketing and manufacturing authorization for Wayrilz in ITP, based on LUNA 3 phase 3 data.
Simantini Singh Deo

Sanofi's Cenrifki gains EC approval for non-relapsing SPMS, introducing mandatory liver monitoring and a phased EU launch starting in Germany.
Simantini Singh Deo

EC approves AbbVie's risankizumab for pediatric psoriasis, introducing a 55 mg weight-based pre-filled syringe for patients under 40 kg.
Simantini Singh Deo
